Johns Hopkins ABX Guide
Tobramycin
Tobramycin is a topic covered in the Johns Hopkins ABX Guide.
To view the entire topic, please log in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
FDA
- UTI
- Septicemia, including serious central nervous system infections (use in combination)
- Lower respiratory tract infections (use in combination)
- Complicated urinary tract infections
- Intra-abdominal infections, including peritonitis (use in combination)
- Skin, bone, and skin structure infections (use in combination)
- Management of cystic fibrosis, with P. aeruginosa (as TOBI inhalation)
- Treatment of ocular infections (uncomplicated conjunctivitis-ophthalmic solution)
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Pneumonia, hospital-acquired (in combination with a beta-lactam, beta-lactam/beta-lactamase inhibitor, or a third/fourth-generation cephalosporin)
- Pseudomonal infections (in combination with a beta-lactam, beta-lactam/beta-lactamase inhibitor, carbapenem or a third/fourth-generation cephalosporin)
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
FDA
FDA
- UTI
- Septicemia, including serious central nervous system infections (use in combination)
- Lower respiratory tract infections (use in combination)
- Complicated urinary tract infections
- Intra-abdominal infections, including peritonitis (use in combination)
- Skin, bone, and skin structure infections (use in combination)
- Management of cystic fibrosis, with P. aeruginosa (as TOBI inhalation)
- Treatment of ocular infections (uncomplicated conjunctivitis-ophthalmic solution)
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Pneumonia, hospital-acquired (in combination with a beta-lactam, beta-lactam/beta-lactamase inhibitor, or a third/fourth-generation cephalosporin)
- Pseudomonal infections (in combination with a beta-lactam, beta-lactam/beta-lactamase inhibitor, carbapenem or a third/fourth-generation cephalosporin)
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: November 2, 2015
Citation
Pham, Paul A, and John G Bartlett. "Tobramycin." Johns Hopkins ABX Guide, The Johns Hopkins University, 2015. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540556/7/Tobramycin.
Pham PA, Bartlett JG. Tobramycin. Johns Hopkins ABX Guide. The Johns Hopkins University; 2015. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540556/7/Tobramycin. Accessed March 21, 2023.
Pham, P. A., & Bartlett, J. G. (2015). Tobramycin. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540556/7/Tobramycin
Pham PA, Bartlett JG. Tobramycin [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2015. [cited 2023 March 21]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540556/7/Tobramycin.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Tobramycin
ID - 540556
A1 - Pham,Paul,Pharm.D.
AU - Bartlett,John,M.D.
Y1 - 2015/11/02/
BT - Johns Hopkins ABX Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540556/7/Tobramycin
PB - The Johns Hopkins University
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
